Advertise on podcast: EyePod

This edition of OT Roundup covers the Nobel Prize in Physiology or Medicine for optogenetics and its link to MCO-010 in retinitis pigmentosa, BRUNELLO phase 2b/3 results for remigromig in diabetic macular edema (DME) with Veeral Sheth, MD, phase 3 DRAGON results for tinlarebant in Stargardt disease, and what the first total human eye transplant has taught surgeons.

In this episode of the Ophthalmology Times® "Beyond the Walls" podcast, host Deborah Ristvedt, DO, sits down with Priya Mathews, MD, a cornea, cataract, and refractive surgeon, dry eye expert, and educator, to explore the experiences and passions that have shaped her career and her approach to patient care. Mathews shares how a mentor sparked a lifelong commitment to dry eye care — a patient population she felt was historically underserved. She discusses building a dedicated dry eye rehab clinic, why treating the ocular surface is essential for premium cataract outcomes, and how her 15-year yoga practice has woven itself into her vision for whole-patient care. From navigating early career self-doubt to designing a practice built around purpose, Mathews offers an honest and inspiring look at what it means to follow your calling in medicine. Check out more episodes of Beyond the Walls at https://www.ophthalmologytimes.com/podcasts/beyond-the-walls#Ophthalmology #EyeCare #BeyondTheWalls #DryEye #OcularSurface #WomenInOphthalmology #Podcast #OphthalmologyTimes

Episode 2 of OT Roundup is here. Lucia Gambuzza and co-host Veeral Sheth, MD, break down 4-year durability data for MOGENRY in retinitis pigmentosa, RCA's first State of Retina Care report, the FDA's upcoming review of SYD-101 for pediatric myopia, and new Phase 2 data on OCU410 for geographic atrophy. MOGENRY 4-year data: https://www.ophthalmologytimes.com/view/retina-society-2026-mco-010-optogenetic-therapy-maintains-visual-acuity-gains-through-4-years-in-advanced-rpRCA's State of Retina Care report: https://www.ophthalmologytimes.com/view/rca-releases-first-state-of-retina-care-reportFDA Advisory Committee on SYD-101: https://www.ophthalmologytimes.com/view/fda-advisory-committee-syd-101-pediatric-myopia-october-30Nimesh Patel, MD on pediatric progressive myopia: https://www.ophthalmologytimes.com/view/pediatric-progressive-myopia-epidemic-permanent-vision-loss OCU410 Phase 2 data: https://www.ophthalmologytimes.com/view/retina-society-2026-medium-dose-ocu410-gene-therapy-cuts-geographic-atrophy-progression-up-to-32-in-phase-2-trial

Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This podcast series explores the overlooked corners of the retina profession through candid conversations with thought leaders. Eichenbaum is the Yiddish word for oak tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding. In this episode, Eichenbaum speaks with two longtime friends and retina drug-development veterans: Andrea Gibson, PhD, executive vice president of medical collaborations at Ocular Therapeutix, and Erin C. Henry, PhD, AVP of Ophthalmology, General and Specialty Medicine, Value and Implementation, Global Medical and Scientific Affairs at Merck Research Labs. Grab a seat for this one — it's part reunion, part masterclass. Gibson and Henry were there at the dawn of anti-VEGF therapy, trading stories from the front lines of a field that changed medicine forever, and 20 years later, they're still just as obsessed with the science. They swap laughs about "stumbling into" careers nobody could have mapped out for them, get real about the mentors who doubted the move to industry, and issue a challenge to the field: stop letting the next generation stumble in the same way they did. Equal parts nostalgia, candor, and a rallying cry for what comes next. Check out more episodes of Eichenbaum Acorns, powered by Modern Retina, at https://www.ophthalmologytimes.com/podcasts/eichenbaum-acorns

The debut episode of OT Roundup, a new biweekly news podcast from Ophthalmology Times. This episode covers new research on ADHD's ocular signature, a surgeon's personal experience with a trifocal IOL, the FDA's acceptance of a gene-agnostic therapy for retinitis pigmentosa, and the AMA's move to classify myopia as a disease—plus Expert Insight from Dr. Veeral Sheth.

In this latest episode of the Ophthalmology Times® “Beyond the Walls” podcast, host Deborah Ristvedt, DO, sits down with Alison D. Early, MD, a cataract and refractive surgeon, innovator, and entrepreneur at Signature Cataract and Laser Consultants in Cincinnati, Ohio, to explore the personal turning point that led Early to step away from the security of a large multispecialty practice and build a practice of her own. The conversation covers the galvanizing patient encounter that changed Early’s trajectory, her philosophy of human-centered care, and her advice to surgeons navigating the early stages of their careers. Check out more episodes of Beyond The Walls athttps://www.ophthalmologytimes.com/podcasts/beyond-the-walls#Ophthalmology #EyeCare #BeyondTheWalls #PrivatePractice #WomenInOphthalmology #PatientExperience #Entrepreneurship #OphthalmologyTimes

Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This podcast series explores the overlooked corners of the retina profession through candid conversations with thought leaders. In this episode, Eichenbaum speaks with David J. Tanzer, MD, ABO, chief medical officer (CMO) at Lexitas Pharma Services, Inc., about a career that travels from the cockpit through clinical practice to the boardroom. A former US Navy flight surgeon turned three-time CMO, Tanzer shares how a chance rotation in San Diego led him into ophthalmology, why he still misses hands-on patient care, and what advice he'd give physicians considering a path beyond pure clinical medicine. Check out more episodes of Eichenbaum Acorns, powered by Modern Retina, at https://www.ophthalmologytimes.com/podcasts/eichenbaum-acorns

In this episode of the Ophthalmology Times® "Beyond The Walls" podcast, host Deborah Ristvedt, DO, sits down with colleague John P. Berdahl, MD, of Vance Thompson Vision, to explore the personal story behind a career defined by curiosity, persistence, and a commitment to giving back. Berdahl shares formative childhood experiences, early struggles in medical school, and the defining moments that shaped his path in ophthalmology. He discusses the innovations that have marked his career, including OPAP, a negative pressure goggle system for glaucoma, and a free toric IOL rotation calculator used by thousands of surgeons each month. He also speaks candidly about a high-profile business failure, the resilience it took to recover, and what he has learned about leadership along the way. The conversation closes with reflections on mentorship, family, and legacy — and what it truly means to give more than you take. Check out more episodes of Beyond The Walls at https://www.ophthalmologytimes.com/podcasts/beyond-the-walls#Ophthalmology #EyeCare #BeyondTheWalls #Innovation #Entrepreneurship #Mentorship #Podcast #OphthalmologyTimes

Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This podcast series explores the overlooked corners of the retina profession through candid conversations with thought leaders. Eichenbaum is the Yiddish word for oak tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding. In this episode, Eichenbaum speaks with Caroline R. Baumal, MD, recently chief medical officer (CMO) of Apellis Pharmaceuticals, about a career that has moved between clinical practice, academic medicine, imaging research, and industry leadership—and what she has learned along the way. Check out other episodes of Eichenbaum Acorns, powered by Modern Retina.

In this podcast, experts Mary Qiu, MD; Paul Singh, MD; and Danica J. Marrelli, OD, FAAO; discuss interventional glaucoma. This more proactive management approach aims to minimize the challenges of topical glaucoma management with the earlier use of procedures.

Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This podcast series explores the overlooked corners of the retina profession through candid conversations with thought leaders. Eichenbaum is the Yiddish word for oak tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding. In this episode, Eichenbaum speaks with Jay S. Duker, MD, president and CEO of EyePoint Pharmaceuticals and a board director, and Ramiro Ribeiro, MD, PhD, chief medical officer of EyePoint Pharmaceuticals, about the professional decisions that led each of them from clinical and academic training into pharmaceutical leadership—and what they have learned along the way.

In this podcast, experts Francis Mah, MD; and Amy Nau, OD, FAAO, Dipl, CCLRT; discuss how to identify neurotrophic keratitis in practice, highlighting indications for corneal sensitivity testing based on patient history and examination findings. Faculty will also examine how to stage and treat neurotrophic keratitis once diagnosed.

In this latest episode of the Ophthalmology Times® “Beyond The Walls” podcast, host Deborah Ristvedt, DO, sits down with her ophthalmology practice partner and mentor Vance Thompson, MD, to explore the origins and ongoing impact of a team first culture at Vance Thompson Vision. The conversation covers Thompson's early frustrations with practice dynamics, his turn toward business education, and the philosophy that has guided his career and practice growth. Thompson traces his thinking back to the late 1990s, when despite working with what he describes as "nice people," his practice was seeing more team and patient complaints than he expected. Encouraged by his brother-in-law, a physician-turned-hospital administrator, Thompson began studying the business side of medicine. He attended a course in Boca Raton, Florida, and worked with Jim Gilmore, coauthor of The Experience Economy, whose framework—"work is theater and every business a stage"—helped him reframe how he thought about patient care delivery. The pivotal insight came when Thompson recognized that teachings focused on the customer, while he was focused on the patient. "The team experience is something that I have to have perfect, we have to have perfect before we're gonna have a great patient experience," he explains. This realization led to what became his signature and deliberately provocative principle: The patient comes second. Thompson acknowledges the reaction that framing typically draws. "I've heard audible gasps from groups of surgeons," he says, adding that the point is not to deprioritize patients but to challenge a culture in medicine where staff are treated "less than." His argument is that an authentically cared-for team creates an environment patients feel immediately. "I don't know exactly what's going on here, but I love how they treat each other and I love how they treat me," he describes patients saying. He also connects team first culture to burnout prevention, recounting a colleague who told him he feared he was burning out. Thompson's response: "Are you operating on eyes or are you operating on people?" Reconnecting with the human dimension of the work, he suggests, is central to sustaining energy across a career. "I always want to remember I'm a doctor first, I'm an ophthalmologist second, I'm a refractive surgeon third." Thompson credits legendary UCLA basketball coach John Wooden with giving him "the guts to use the L word in the workplace," drawing a distinction between the love shared with family and a professional love rooted in genuine care for colleagues. He describes this openly with prospective partners: "I want them to know about the mush of me from the beginning," noting that those not open to that kind of relationship will eventually leave. He concludes that he views shared values around caring for fellow humans as a foundation for both culture and growth at Vance Thompson Vision.

Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This podcast series explores the overlooked corners of the retina profession through candid conversations with thought leaders. Eichenbaum is the Yiddish translation for acorn tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding. In this episode of Eichenbaum Acorns, Eichenbaum speaks with Christina Y. Weng, MD, MBA, FASRS, about her career path, mentorship, education, and evolving clinical research in retina. Weng, who is professor and the Alice R. McPherson Retina Research Foundation Chair in Ophthalmology, and fellowship program director, vitreoretinal diseases and surgery with Baylor College of Medicine in Houston, Texas, reflects on joining Baylor straight out of fellowship at Bascom Palmer Eye Institute in Miami, Florida, and building her career there over more than a decade.  Fun fact! Christina Y. Weng, MD, MBA, FASRS, is also host of The Retina TL;DR, powered by Modern Retina. Check out these episodes!

Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This podcast series explores the overlooked corners of the retina profession through candid conversations with thought leaders. Eichenbaum is the Yiddish translation for acorn tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding. In this special cross-brand episode with Optometry Times, Eichenbaum speaks with Jeffry D. Gerson, OD, FAAO, about career development, mentorship, and collaboration between optometry and ophthalmology in retinal care.  Gerson practices in a collaborative OD-MD setting at Grin Eye Care in Olathe and Leawood, Kansas, where his work includes primary care as well as secondary care with an emphasis on retinal disease.